Mission: 

Use deep tech to democratize advanced diabetes care in India and other low / middle income countries (LMICs), through cutting-edge and affordable medical devices

Problem:

India has 140 mn+ diabetics, 5%  of which are Type 1 with a high mortality rate of 33%. LMICs rely on insulin injections which are painful and have a huge risk of potentially fatal glycemic fluctuation.

Medically, the best line of treatment for diabetics is “an insulin infusion pump coupled with a glucose monitor”, which is well established in the US and EU.
However, in India
- This technology is prohibitively unaffordable
- Neither is it designed for India / other LMICs and local conditions
- Nor does insurance cover this technology unlike the developed economies

Solution:

Use deep tech to disrupt this market with "An insulin infusion pump and a glucose monitor", that are Made in India, for the global market
   - Target Price point: 1/10th of current
   - Markets: India, followed by SE Asia, South Asia, Africa, followed by US, EU, ANZ
   - Users
          - Insulin Pump: Type 1 and insulin dependent Type 2 diabetics
          - CGM: Type 1 and Type 2 diabetics, Wellness users

India needs a Maruti Suzuki and not a Mercedes!

Renu MedTech

Org chart

Teams

Offices